Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 16.40 as of Friday, August 7, 2026.
Forward PE Ratio (16.40) = Close Price ($88.13) / Consensus Forward EPS ($5.38)
FORWARD PE RATIO
16.40
SECTOR MEDIAN · HEALTHCARE
19.89
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
-17.57%
vs the sector median at left
Henry Schein, Inc.
Market Cap
$10.04B
Forward PE Ratio
16.40
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Henry Schein, Inc. (HSIC) | $10.04B | 16.40 |
| Molina Healthcare, Inc. (MOH)vs › | $10.25B | N/A |
| Insulet Corp. (PODD)vs › | $9.78B | 21.38 |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | 7.65 |
| Universal Health Services, Inc. (UHS)vs › | $10.51B | 7.50 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.49B | 35.52 |
| Tempus AI, Inc. (TEM)vs › | $9.12B | N/A |
| Bio-Techne Corporation (TECH)vs › | $11.32B | 37.39 |
| DaVita Inc. (DVA)vs › | $11.80B | 12.21 |
| Align Technology, Inc. (ALGN)vs › | $12.44B | 14.99 |
Trailing P/E
26.7
reported TTM EPS
Forward P/E
16.4
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $5.38 implies +62.5% EPS growth vs the reported trailing $3.31.
At today's $88.13 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-27 | $5.38 | $5.29 – $5.47 | 11 | 16.4x |
| 2027-12-27 | $6.00 | $5.81 – $6.38 | 11 | 14.7x |
| 2028-12-27 | $6.61 | $5.91 – $7.21 | 6 | 13.3x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
